HANOI, VIETNAM – Media OutReach – November 30, 2023 – A recent publication in the journal Scientific Reports – Nature has once again highlighted clinical trials of
LiveSpo Navax spore probiotic spray. These trials focus on its effectiveness against airway inflammation caused by the flu virus. This news marks an important milestone for the Vietnamese medical sector, notably creating a global trend in the research and application of spore probiotics for respiratory well-being.
The use of a nasal spray containing Bacillus probiotics in the treatment of influenza patients significantly reduced the total duration of treatment, by up to 60% (from five days for the control group to only two days for the spray group). spore probiotics).
In addition, it increased the effectiveness of the treatment by 58 percent, contributing to the complete cure of symptoms such as runny nose, fever, sneezing, cough, rapid heartbeat and rapid breathing. The reduction in clinical symptoms corresponds to a reduction in the number of viruses and bacteria, notably decreasing by approximately 400 and 1,000 times on the second day of treatment compared to the first day of hospitalization.
Clinical trials confirm that the nasal spray containing Bacillus probiotics reduces the duration of treatment, thereby reducing the risk of bacterial infection or serious respiratory tract complications. This not only reduces treatment costs, but also reduces the consumption of antibiotics in the event of infection, thereby promoting the improvement of patient health. This positive signal is crucial for the medical community because it helps ease the burden on hospitals during outbreaks.
Additionally, clinical trials indicate that Bacillus probiotics, when formulated in spray form, provide superior effectiveness through their interaction with the immune system of the mucosa of the nasal cavity. This means that the spore probiotic nasal spray not only supports the treatment of patients infected with influenza, but also helps treat inflammation of the respiratory tract caused by other viruses such as RSV, adenovirus, rhinovirus , coronavirus, etc. Regular use of Bacillus probiotic spray proves beneficial. by strengthening the respiratory barrier, thereby enhancing the effectiveness of virus prevention vaccines.
Probiotics, also known as a type of medicinal probiotics, are an effective solution for relieving the symptoms of respiratory illnesses. In a previous study published in the journal Scientific Reports – Nature in July 2022, LiveSpo Navax supported the treatment of respiratory syncytial virus (RSV) in children. It significantly reduced the duration of treatment by more than a day and lowered the concentration of RSV by more than 600 times, surpassing the effectiveness of using physiological saline. This scientific research ranked among the top 100 most downloaded microbiology articles of 2022 in the Nature Journal, demonstrating widespread interest from scientists and readers around the world and bringing significant values to the community.
The two internationally validated clinical studies confirmed that LiveSpo Navax nasal spray, containing Bacillus probiotics, demonstrated no side effects, guaranteeing complete safety for children. All patients using LiveSpo Navax in combination with standard treatment medications showed no signs of local bacterial infection or digestive problems such as vomiting, diarrhea or other abnormal symptoms. Therefore, in the future, this product can perfectly be included in the treatment plans of patients infected with respiratory viruses or bacteria.
Dr. Nguyen Hoa Anh, Director of Spore Probiotics Research Center, said: “We are proud to offer an effective support solution for patients suffering from respiratory infections caused by viruses, bacteria or acute inflammation. In the future, we will continue to research, develop, and offer the LiveSpo Navax product to consumers in Vietnam and around the world.
With revolutionary technology in the field of spore probiotics – medicinal probiotics, LiveSpo Pharma aims to build an antibiotic-free future for all. Dang Quoc Hung, CEO of LiveSpo Pharma, said: “At LiveSpo, we always strive to provide the best products to our customers and the community. Thanks to the expertise of our scientific team, which has achieved remarkable research milestones in microbiology at the national and international level, we are confident in the development and manufacturing of effective and practical spore probiotic products without side effects. This effort helps reduce the use of antibiotics and minimize antibiotic resistance in Viet Nam and around the world. This is also LiveSpo’s development mission.
As confirmed by the two successful publications in the prestigious journal Scientific Reports – Nature, LiveSpo affirmed its breakthrough in products resulting from the company’s extensive research and development efforts. LiveSpo is proud to introduce Vietnamese spore probiotic technology to developed country markets that are at the forefront of global medical advancements. This groundwork paves the way for the future growth of Vietnamese businesses, with a focus on expanding into global markets and promoting Vietnamese brands and products internationally.
With a focus on product development, LiveSpo aims to create value for the community. The company’s successful development of the Bacillus probiotic spray, which effectively facilitates the treatment of respiratory diseases and minimizes the risk of severe inflammation and prolonged antibiotic use, helps pave the way for a future less dependent on antibiotics.
By their nature as a type of medical probiotic, LiveSpo products will help strengthen the body’s natural immune barrier when used over an extended period of time, thereby contributing to the community immune system if applied widely. This serves as a natural shield, protecting the community from diseases caused by viruses and bacteria.
Hashtag: #Livespo
The issuer is solely responsible for the content of this announcement.
